Diabetes Care

Metabolic

8 drugs in development·1 company·1 clinical trial

Drug Pipeline by Phase

Unknown(4)

Drug	Company
AMP-005	Amphastar Pharmaceuticals, Inc. (AMPH)
AMP-025	Amphastar Pharmaceuticals, Inc. (AMPH)
Insulin Degludec (AMP-025)	Amphastar Pharmaceuticals, Inc. (AMPH)
Recombinant Human Insulin (AMP-005)	Amphastar Pharmaceuticals, Inc. (AMPH)

Phase 2/Phase 3(4)

Drug	Company
AMP-004	Amphastar Pharmaceuticals, Inc. (AMPH)
AMP-004m	Amphastar Pharmaceuticals, Inc. (AMPH)
Insulin Aspart (AMP-004)	Amphastar Pharmaceuticals, Inc. (AMPH)
Unnamed biosimilar insulin candidate (on file with FDA)	Amphastar Pharmaceuticals, Inc. (AMPH)

BioSniper tracks 8 drugs in development for Diabetes Care across 1 company.

There are 1 clinical trial targeting Diabetes Care tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.